The Conduent breach, called the largest in U.S. history by Texas AG Ken Paxton, exposed…
America’s obesity crisis meets the Ozempic boom as data reveals GLP-1 hot spots
Insurance data reveals dramatic regional differences in Ozempic and Mounjaro usage, with obesity-heavy states prescribing GLP-1 medications at triple the rate of others.
Related Posts
